Tag: Dapagliflozin
Lilly oral GLP-1 orforglipron’s successful Phase 3 trials
Eli Lilly and Company has announced positive topline results from the Phase 3 Achieve-2 and Achieve -5 trials. Achieve -2, the second head-to-head trial...
Nectar Life Care’s anti-diabetic range
Nectar Life Care has announced the launch of a new range of high-quality, cost-effective anti-diabetic formulations, with Dapagliflozin under the brand name DAPNEC. With...